[Diabetic cardiomyopathy].
Terashima
Masahiro
M
National Cardiovascular Center.
Goto
Yoichi
Y
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D048909:Diabetes Complications; D004656:Enalapril / Q000627:therapeutic use; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D011379:Prognosis; D016277:Ventricular Function, Left
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D017127:Glycation End Products, Advanced; D004656:Enalapril